John W. Auteur Dominiczak Marek H. Auteur Baynes

John W. Auteur Dominiczak Marek H. Auteur Baynes's AcademicInfluence.com Rankings

Philosophy

#4231

World Rank

#6677

Historical Rank

Logic

#1735

World Rank

#2571

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is John W. Auteur Dominiczak Marek H. Auteur Baynes Influential?

(Suggest an Edit or Addition)

(See a Problem?)

John W. Auteur Dominiczak Marek H. Auteur Baynes's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Role of Oxidative Stress in Development of Complications in Diabetes (1991) (4011)
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. (1999) (2493)
Effect of Collagen Turnover on the Accumulation of Advanced Glycation End Products* (2000) (808)
The Advanced Glycation End Product, N-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation Reactions (*) (1996) (779)
Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. (1986) (767)
Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. (2003) (731)
Simple non-invasive assessment of advanced glycation endproduct accumulation (2004) (651)
Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. (1995) (575)
N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. (1997) (561)
Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. (1991) (532)
Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications. (1999) (513)
Glycoxidation and lipoxidation in atherogenesis. (2000) (498)
Accumulation of Maillard Reaction Products in Skin Collagen in Diabetes and Aging a (1992) (491)
Maillard reaction products in tissue proteins: New products and new perspectives (2003) (488)
N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. (1995) (485)
Glycation, Glycoxidation, and Cross-Linking of Collagen by Glucose: Kinetics, Mechanisms, and Inhibition of Late Stages of the Maillard Reaction (1994) (479)
Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis. (2002) (444)
Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. (1993) (429)
Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat. (2002) (377)
Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. (2005) (362)
Role of the Maillard Reaction in Aging of Tissue Proteins (1998) (362)
The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. (2002) (343)
Age-related accumulation of Maillard reaction products in human articular cartilage collagen. (2000) (331)
A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease. (2009) (323)
Accumulation of Maillard reaction products in skin collagen in diabetes and aging. (1993) (322)
The role of AGEs in aging: causation or correlation (2001) (319)
Nonenzymatically glucosylated albumin. In vitro preparation and isolation from normal human serum. (1979) (312)
Chelating Activity of Advanced Glycation End-product Inhibitors* (2001) (310)
Role of the Maillard Reaction in Diabetes Mellitus and Diseases of Aging (1996) (284)
Age-dependent accumulation of N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl)hydroxylysine in human skin collagen. (1991) (279)
Amadorins: novel post-Amadori inhibitors of advanced glycation reactions. (1999) (274)
Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein. (1997) (267)
Glyoxalase‐1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans (2008) (266)
Chemical modification of proteins by methylglyoxal. (1998) (261)
Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus. (1979) (260)
Pyridoxamine, an Inhibitor of Advanced Glycation Reactions, Also Inhibits Advanced Lipoxidation Reactions (2000) (250)
Oxidation of glycated proteins: age-dependent accumulation of N epsilon-(carboxymethyl)lysine in lens proteins. (1989) (236)
Aberrant succination of proteins in fumarate hydratase‐deficient mice and HLRCC patients is a robust biomarker of mutation status (2011) (231)
Formation of o-tyrosine and dityrosine in proteins during radiolytic and metal-catalyzed oxidation. (1993) (220)
Role of Glycation in Modification of Lens Crystallins in Diabetic and Nondiabetic Senile Cataracts (1991) (205)
Nonenzymatic glucosylation and glucose-dependent cross-linking of protein. (1983) (202)
A Post-Amadori Inhibitor Pyridoxamine Also Inhibits Chemical Modification of Proteins by Scavenging Carbonyl Intermediates of Carbohydrate and Lipid Degradation* (2002) (199)
Nonenzymatic Glucosylation of Serum Proteins in Diabetes Mellitus (1979) (198)
Chelation: A Fundamental Mechanism of Action of AGE Inhibitors, AGE Breakers, and Other Inhibitors of Diabetes Complications (2012) (196)
Mice deficient in both Mn superoxide dismutase and glutathione peroxidase-1 have increased oxidative damage and a greater incidence of pathology but no reduction in longevity. (2009) (191)
The Regulation of Skeletal Muscle Protein Turnover during the Progression of Cancer Cachexia in the ApcMin/+ Mouse (2011) (189)
Simple Noninvasive Measurement of Skin Autofluorescence (2005) (186)
The Amadori product on protein: structure and reactions. (1989) (179)
IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin/+ mouse (2012) (179)
Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications. (2003) (176)
The role of oxidative stress in diabetic complications (1996) (172)
The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats. (2003) (172)
Non-enzymatic glycosylation and the chronic complications of diabetes: an overview (1984) (165)
Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy (2005) (164)
Pathways of formation of glycoxidation products during glycation of collagen. (1995) (162)
New biomarkers of Maillard reaction damage to proteins. (1996) (161)
The role of AGEs and AGE inhibitors in diabetic cardiovascular disease. (2005) (157)
S-(2-Succinyl)cysteine: a novel chemical modification of tissue proteins by a Krebs cycle intermediate. (2006) (155)
Reaction of ascorbate with lysine and protein under autoxidizing conditions: formation of N epsilon-(carboxymethyl)lysine by reaction between lysine and products of autoxidation of ascorbate. (1990) (154)
Role of Oxygen in Cross-Linking and Chemical Modification of Collagen by Glucose (1992) (151)
Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia? (1998) (150)
Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus. (1991) (148)
Age-dependent increase in ortho-tyrosine and methionine sulfoxide in human skin collagen is not accelerated in diabetes. Evidence against a generalized increase in oxidative stress in diabetes. (1997) (147)
The Maillard Hypothesis on Aging: Time to Focus on DNA (2002) (146)
Immunohistochemical and ELISA Assays for Biomarkers of Oxidative Stress in Aging and Disease a (1998) (144)
Enrichment and analysis of nonenzymatically glycated peptides: boronate affinity chromatography coupled with electron-transfer dissociation mass spectrometry. (2007) (143)
Muscle oxidative capacity during IL-6-dependent cancer cachexia. (2011) (142)
Glycation of amino groups in protein. Studies on the specificity of modification of RNase by glucose. (1985) (140)
Oxidized amino acids in lens protein with age. Measurement of o-tyrosine and dityrosine in the aging human lens. (1993) (138)
The Maillard Reaction: Chemistry, Biochemistry and Implications (2005) (137)
Imidazolium crosslinks derived from reaction of lysine with glyoxal and methylglyoxal are increased in serum proteins of uremic patients: evidence for increased oxidative stress in uremia (1998) (129)
Caloric restriction decreases age-dependent accumulation of the glycoxidation products, N epsilon-(carboxymethyl)lysine and pentosidine, in rat skin collagen. (1995) (128)
Nonenzymatic glucosylation of rat albumin. Studies in vitro and in vivo. (1979) (128)
Gut barrier dysfunction in the Apc(Min/+) mouse model of colon cancer cachexia. (2011) (121)
Maillard reactions in chemistry, food, and health (1994) (118)
Detection of 3-deoxyfructose and 3-deoxyglucosone in human urine and plasma: evidence for intermediate stages of the Maillard reaction in vivo. (1992) (117)
Effect of Diabetes and Aging on Carboxymethyllysine Levels in Human Urine (1991) (116)
Inactivation of Glyceraldehyde-3-Phosphate Dehydrogenase by Fumarate in Diabetes (2008) (116)
Pyridoxamine Traps Intermediates in Lipid Peroxidation Reactions in Vivo (2003) (113)
Effect of phosphate on the kinetics and specificity of glycation of protein. (1987) (110)
National Diabetes Data Group: Report of the Expert Committee on Glucosylated Hemoglobin (1984) (108)
Oxidative degradation of glucose adducts to protein. Formation of 3-(N epsilon-lysino)-lactic acid from model compounds and glycated proteins. (1988) (108)
Effect of glycosylation on the in vivo circulating half-life of ribonuclease. (1976) (108)
Nonenzymatic Glucosylation of Serum Proteins and Hemoglobin: Response to Changes in Blood Glucose Levels in Diabetic Rats (1980) (107)
The effect of exercise on IL-6-induced cachexia in the ApcMin/+ mouse (2011) (107)
Effect of antioxidants and ACE inhibition on chemical modification of proteins and progression of nephropathy in the streptozotocin diabetic rat (2004) (104)
The anti-cancer drug, doxorubicin, causes oxidant stress-induced endothelial dysfunction. (2006) (103)
The serum concentration of the advanced glycation end-product Nε-(carboxymethyl)lysine is increased in uremia: Technical Note (1997) (102)
Metabolism of fructose-3-phosphate in the diabetic rat lens. (1995) (101)
Carboxymethylethanolamine, a Biomarker of Phospholipid Modification during the Maillard Reaction in Vivo * (1997) (101)
Succination of Thiol Groups in Adipose Tissue Proteins in Diabetes (2009) (100)
Succination of Protein Thiols during Adipocyte Maturation (2007) (99)
Cadmium and mercury cause an oxidative stress-induced endothelial dysfunction (2007) (95)
Formation of reactive intermediates from Amadori compounds under physiological conditions. (1995) (95)
The Maillard reaction in vivo (1991) (87)
From life to death – the struggle between chemistryand biology during aging: the Maillard reaction as an amplifier of genomic damage (2004) (86)
Carbohydrate-mediated clearance of immune complexes from the circulation. A role for galactose residues in the hepatic uptake of IgG-antigen complexes. (1980) (86)
The role of a dolichol-oligosaccharide as an intermediate in glycoprotein biosynthesis. (1974) (85)
Characterization of an Imidazolium Salt Formed from Glyoxal and N.alpha.-Hippuryllysine: A Model for Maillard Reaction Crosslinks in Proteins (1995) (85)
The role of mannosyl-phosphoryl-dihydropolyisoprenol in the synthesis of mammalian glycoproteins. (1973) (83)
[8] Nonenzymatic glucosylation of lysine residues in albumin (1984) (83)
Role of lipids in chemical modification of proteins and development of complications in diabetes. (2003) (82)
Chemistry of the fructosamine assay: D-glucosone is the product of oxidation of Amadori compounds. (1994) (79)
AGE-breakers cleave model compounds, but do not break Maillard crosslinks in skin and tail collagen from diabetic rats. (2003) (79)
Noninvasive, optical detection of diabetes: model studies with porcine skin. (2004) (78)
Proteomic analysis of the site specificity of glycation and carboxymethylation of ribonuclease. (2003) (77)
Chemical Modification of Proteins by Lipids in Diabetes (2003) (75)
Studies of renal injury III: lipid-induced nephropathy in type II diabetes. (2000) (74)
Presence of dopa and amino acid hydroperoxides in proteins modified with advanced glycation end products (AGEs): amino acid oxidation products as a possible source of oxidative stress induced by AGE proteins. (1998) (73)
Succination of Proteins by Fumarate (2008) (71)
The succinated proteome. (2014) (70)
What is the Future of Diabetic Wound Care? (2006) (68)
Carbohydrate-mediated clearance of antibody . antigen complexes from the circulation. The role of high mannose oligosaccharides in the hepatic uptake of IgM . antigen complexes. (1980) (67)
The Regulation of Skeletal Muscle Protein Turnover During the Progression of Cancer Cachexia in the Apc Min / + Mouse (2019) (66)
13C NMR investigation of nonenzymatic glucosylation of protein. Model studies using RNase A. (1983) (65)
Improved methods for the enrichment and analysis of glycated peptides. (2008) (63)
Chemical modification of muscle protein in diabetes. (2004) (62)
Is human aging still mysterious enough to be left only to scientists? (2002) (61)
Succination of proteins in diabetes (2011) (60)
Identification of the sites of IgG catabolism in the rat. (1982) (60)
Citric acid inhibits development of cataracts, proteinuria and ketosis in streptozotocin (type 1) diabetic rats. (2010) (58)
3-Deoxyfructose Concentrations are Increased in Human Plasma and Urine in Diabetes (1994) (57)
Lipid peroxidation and protein modification in a mouse model of chronic iron overload. (2002) (57)
Thyroid status modulates glycoxidative and lipoxidative modification of tissue proteins. (1999) (56)
The reaction of hyaluronic acid and its monomers, glucuronic acid and N-acetylglucosamine, with reactive oxygen species. (1999) (56)
The design and application of residualizing labels for studies of protein catabolism (1993) (53)
Nonenzymatic glucosylation of lysine residues in albumin. (1984) (53)
Glycosylation of low density lipoprotein in patients with Type I (insulin-dependent) diabetes: Correlations with other parameters of glycaemic control (1986) (52)
Advanced glycation end-products and methionine sulphoxide in skin collagen of patients with type 1 diabetes (2006) (52)
125I-glycoconjugate labels for identifying sites of protein catabolism in vivo: effect of structure and chemistry of coupling to protein on label entrapment in cells after protein degradation. (1985) (51)
Proteomic Analysis of Arginine Adducts on Glyoxal-modified Ribonuclease* (2004) (50)
Mitochondrial stress causes increased succination of proteins in adipocytes in response to glucotoxicity. (2012) (49)
Characterization of an imidazolium compound formed by reaction of methylglyoxal and N-hippuryllysine (1995) (49)
Renal Effects of Oral Maillard Reaction Product Load in the Form of Bread Crusts in Healthy and Subtotally Nephrectomized Rats (2005) (47)
Dietary Bread Crust Advanced Glycation End Products Bind to the Receptor for AGEs in HEK‐293 Kidney Cells but Are Rapidly Excreted after Oral Administration to Healthy and Subtotally Nephrectomized Rats (2005) (46)
Renal accumulation and clearance of advanced glycation end-products in type 2 diabetic nephropathy: effect of angiotensin-converting enzyme and vasopeptidase inhibition (2005) (45)
Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia (2007) (45)
Identification of the sites of albumin catabolism in the rat. (1981) (44)
Increased methionine sulfoxide content of apoA-I in type 1 diabetes Published, JLR Papers in Press, January 17, 2008. (2008) (43)
CML: a brief history (2002) (43)
Cardiac and renal function are progressively impaired with aging in Zucker diabetic fatty type II diabetic rats (2009) (42)
Tissue Distribution of S‐(2‐Succino)cysteine (2SC), a Biomarker of Mitochondrial Stress in Obesity and Diabetes (2012) (41)
Detection and identification of arginine modifications on methylglyoxal-modified ribonuclease by mass spectrometric analysis. (2007) (39)
Oxygen is not required for the browning and crosslinking of protein by pentoses: relevance to Maillard reactions in vivo. (1999) (38)
Menadione causes endothelial barrier failure by a direct effect on intracellular thiols, independent of reactive oxidant production. (2003) (38)
Stimulation of cholesteryl ester synthesis in human monocyte-derived macrophages by low-density lipoproteins from Type 1 (insulin-dependent) diabetic patients: the influence of non-enzymatic glycosylation of low-density lipoproteins (1987) (38)
Aminoguanidine inhibits albuminuria, but not the formation of advanced glycation end-products in skin collagen of diabetic rats. (1999) (38)
Nonenzymatic glycosylation of protein does not increase with age in normal human lenses. (1990) (38)
The effect of alpha-mannose-terminal oligosaccharides on the survival of glycoproteins in the circulation. Rapid uptake and catabolism of bovine pancreatic ribonuclease B by nonparenchymal cells of rat liver. (1978) (36)
Technical note. The serum concentration of the advanced glycation end-product N epsilon-(carboxymethyl)lysine is increased in uremia. (1997) (35)
Tissue‐Specific Variation in Glycation of Proteins in Diabetes: Evidence for a Functional Role of Amadoriase Enzymes (2005) (35)
The Metal Chelators, Trientine and Citrate, Inhibit the Development of Cardiac Pathology in the Zucker Diabetic Rat (2009) (35)
Mechanism of fructosamine assay: evidence against role of superoxide as intermediate in nitroblue tetrazolium reduction. (1993) (35)
Glutaraldehyde is an effective cross-linker for production of antibodies against advanced glycation end-products. (2008) (35)
Identification of fibroblasts as a major site of albumin catabolism in peripheral tissues. (1986) (35)
Chemical modification of proteins during peroxidation of phospholipids Published, JLR Papers in Press, April 1, 2005. DOI 10.1194/jlr.M400442-JLR200 (2005) (34)
N epsilon-(carboxymethyl)lysine (CML) as a biomarker of oxidative stress in long-lived tissue proteins. (2002) (33)
Measurement of nonenzymatically glucosylated serum protein by an improved thiobarbituric acid assay. (1983) (32)
Prevention of retinal capillary basement membrane thickening in diabetic dogs by a non-steroidal anti-inflammatory drug (2003) (31)
Dietary ALEs are a risk to human health--NOT! (2007) (28)
Medical biochemistry [4th ed.] (2014) (27)
Clinical Value of Glycosylated Serum Protein and Glycosylated Hemoglobin Levels in the Diagnosis of Gestational Diabetes Mellitus (1984) (27)
[3H]Raffinose, a novel radioactive label for determining organ sites of catabolism of proteins in the circulation. (1979) (27)
A fluorescent residualizing label for studies on protein uptake and catabolism in vivo and in vitro. (1990) (27)
Changes in Blood Protein Glycosylation During a Diabetes Summer Camp (1984) (27)
Quantification of N-(glucitol)ethanolamine and N-(carboxymethyl)serine: two products of nonenzymatic modification of aminophospholipids formed in vivo. (1999) (26)
Oxygen and Life (2009) (26)
Effect of advanced glycation end products on oxidative stress in endothelial cells in culture: a warning on the use of cells studied in serum-free media (2001) (26)
Isotope dilution gas chromatography/mass spectrometry method for the determination of methionine sulfoxide in protein. (2001) (24)
Glycation and Autoxidation of Proteins in Aging and Diabetes (1992) (23)
Characterization of glycated proteins by 13C NMR spectroscopy. Identification of specific sites of protein modification by glucose. (1985) (22)
Renal accumulation of pentosidine in non-diabetic proteinuria-induced renal damage in rats. (2005) (20)
Effect of Glucose Concentration on Formation of AGEs in Erythrocytes in Vitro (2005) (19)
In vivo fate of hemopexin and heme-hemopexin complexes in the rat. (1993) (19)
Albumin catabolism in diabetic rats. (1983) (19)
The clinical chemome: a tool for the diagnosis and management of chronic disease. (2004) (19)
Elements of diabetic nephropathy in a patient with GLUT 2 deficiency. (2005) (19)
SUCCINATION* OF PROTEIN THIOLS DURING ADIPOCYTE MATURATION – A BIOMARKER OF MITOCHONDRIAL STRESS (2007) (17)
SECTION 6 – Nonenzymatic Glycosylation of Proteins in Vitro and in Vivo (1982) (17)
Inulin-125I-tyramine, an improved residualizing label for studies on sites of catabolism of circulating proteins. (1988) (16)
Non-invasive detection of protein metabolism in vivo by n.m.r. spectroscopy. Application of a novel 19F-containing residualizing label. (1989) (15)
The reaction of 3-deoxy-D-glycero-pentos-2-ulose ("3-deoxyxylosone") with aminoguanidine. (1991) (15)
Glycation and Glycoxidation in Diabetic Vascular Disease (2000) (15)
Pre-enrichment of modified low density lipoproteins with alpha-tocopherol mitigates adverse effects on cultured retinal capillary cells. (1999) (15)
Chelation therapy: overlooked in the treatment and prevention of diabetes complications? (2013) (15)
Role of metal-catalyzed autoxidation in Maillard reaction damage to proteins in vivo. (1994) (15)
Frontiers in research on the Maillard reaction in aging and chronic disease (2014) (15)
The Maillard reaction in aging, diabetes, and nutrition : proceedings of an NIH Conference on the Maillard Reaction in Aging, Diabetes, and Nutrition, held in Bethesda, Maryland, September 22-23, 1988 (1989) (14)
Chelation therapy for the management of diabetic complications: a hypothesis and a proposal for clinical laboratory assessment of metal ion homeostasis in plasma (2014) (14)
Catabolism of hirudin and thrombin-hirudin complexes in the rat. (1993) (14)
Development of an UPLC mass spectrometry method for measurement of myofibrillar protein synthesis: application to analysis of murine muscles during cancer cachexia. (2013) (13)
o‐Tyrosine and Dityrosine Concentrations in Oxidized Proteins and Lens Proteins with Age a (1992) (13)
The effect of α-mannose-terminal oligosaccharides on the survival of glycoproteins in the circulation (1978) (13)
Studies in vivo of the tissue uptake, cellular distribution and catabolic turnover of exogenous glucocerebrosidase in rat. (1981) (12)
Formation of methionine sulfoxide during glycoxidation and lipoxidation of ribonuclease A. (2007) (12)
Glycation of wood frog (Rana sylvatica) hemoglobin and blood proteins: in vivo and in vitro studies. (2009) (11)
Mass spectrometric analysis of glucose-modified ribonuclease. (2003) (10)
Proteomic Method for the Quantification of Methionine Sulfoxide (2005) (10)
Role of Carbonyl Stress in Aging and Age-Related Diseases (2005) (10)
AGEing growth factors: a role in diabetic vascular disease? (1994) (10)
Measurement of pentosidine in biological samples. (2000) (9)
Effects of dietary Nε-carboxymethyllysine on expression of the biotransformation enzyme, glutathione-S-transferase, in the rat (2002) (9)
Accumulation of Maillard Reaction Products in Tissue Proteins (1990) (8)
Effects of Aspirin on Glycation, Glycoxidation, and Crosslinking of Collagen (2005) (7)
The Maillard Reaction: Chemistry, Biochemistry and Implications By Harry Nursten (The University of Reading, Reading, U.K.). Royal Society of Chemistry: Cambridge. 2005. xii + 214 pp. $199.00. ISBN 0-85404-964-9. (2005) (7)
ROLE OF OXIDATIVE STRESS IN DEVELOPMENT OF COMPLI-CATIONS OF DIABETES (1991) (7)
Pyridoxamine, a versatile inhibitor of advanced glycation and lipoxidation reactions (2002) (7)
Pathways of the Maillard Reaction In Vitro and In Vivo (2005) (7)
Glycation Does Not Alter LDL‐Induced Secretion of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor‐1 from Human Aortic Endothelial Cells (2005) (6)
Identification of liver endothelial cells as the primary site of IgM catabolism in the rat. (1995) (6)
Intracellular processing of residualizing labels in different cell types in vitro (1990) (6)
Structure-based Ligand Design. Klaus Gubernator and Hans-J. Böhm, editors (Methods and Principles in Medicinal Chemistry, vol. 6.) (1999) (5)
IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin/+ mouse (2012) (5)
Comprar Medical Biochemistry, 3rd Edition | Marek Dominiczak | 9780323053716 | Mosby (2009) (5)
Lipid‐Derived Modifications of Plasma Proteins in Experimental and Human Diabetes (2005) (5)
Skin Autofluorescence, a Noninvasive Measure of Advanced Glycation End Product Accumulation, Is a Predictor of Mortality in Hemodialysis Patients (2005) (4)
Residualizing glycoconjugates: biologically inert tracers for studies on protein endocytosis and catabolism. (1994) (4)
Purification of residualizing glycoconjugate labels for protein by reversed-phase high-pressure liquid chromatography. (1988) (4)
Role of dyslipidemia and AGEALE formation in the progression of nephropathy and retinopathy in STZ-diabetic rats (2002) (3)
Characterization of a triazine (2-[(3-amino-1,2,4-triazin-5-yl)methylene]-hydrazinecarboximideamide) formed from glucose and aminoguanidine under oxidative conditions (1993) (3)
Modification of Cysteine Residues in Protein by Endogenous Oxidants and Electrophiles (2010) (3)
Oxidative Metabolism of Lipids in Liver and Muscle (2009) (2)
Synthesis of N,N-dilactitol ethylenediamine: a versatile spacer for attachment of residualizing labels to protein. (1992) (2)
Anaerobic Metabolism of Glucose in the Red Blood Cell (2009) (2)
Advanced Glycation Endproducts and the Absence of Premature Atherosclerosis in Glycogen Storage Disease 1a (2007) (2)
Carbohydrate Storage and Synthesis in Liver and Muscle (2009) (2)
DEVELOPMENT OF AN ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY- MASS SPECTROMETRY METHOD FOR MEASUREMENT OF MYOFIBRILLAR PROTEIN SYNTHESIS: APPLICATION TO ANALYSIS OF MURINE MUSCLES DURING CANCER CACHEXIA (2012) (2)
Irish endocrine society (1990) (2)
Comprar Medical Biochemistry + Online Access 4th Ed. | J. Baynes | 9781455745807 | Saunders (2014) (2)
Cleavage of Dicarbonyl Compounds by the Advanced Glycation/Lipoxidation End Product Inhibitor Pyridoxamine (2005) (1)
IL-6 Regulation on Skeletal Muscle Mitochondrial Remodeling During Cancer Cachexia in the ApcMin/+ Mouse (2020) (1)
Isolation and characterization of a major product formed from glucose and aminoguanidine under physiological conditions in vitro (1992) (1)
Characterization of Glycated Proteins by 13 C (1984) (1)
Carbohydrate-mediated Clearance of Immune Circulation (2001) (1)
Advanced Glycation Endproducts and the Absence of Premature Atherosclerosis in Glycogen Storage Disease 1 a (2019) (1)
Determination of the specific activity of NaB3H4. (1983) (1)
Treadmill Exercise And Glucose Clearance In ApcMin/+ Mice: 1573 (2010) (1)
Mechanismof Fructosamine Assay:EvidenceagainstRoleof Superoxideas Intermediatein NitroblueTetrazoliumReduction (1993) (1)
IL‐6 inhibition attenuates activation of ubiquitin proteasome‐dependent degradation in cachectic muscle (2011) (1)
Inhibition of advanced glycation/lipoxidation endproducts (AGEs/ALEs) prevents retinopathy in experimental diabetes (2001) (1)
IL-6 Regulation on Skeletal Muscle Mitochondrial Remodeling During Cancer Cachexia in the ApcMin/+ Mouse (2020) (1)
Life extension in Caenorhabditis elegans by overexpression of Glyoxalase I — A mechanistic integration of protein damage by glycation, oxidation and nitratio (2007) (1)
Effect of Glucose Concentration on the Formation of Advanced Glycation End Products in Erythrocytes in Vitro (2005) (0)
Use of fluorescence and near-infrared spectroscopies for noninvasive measurement of skin-collagen Advanced Glycation Endproducts: a feasibility study (2004) (0)
Glycation and oxidation of proteins in diabetes & aging: Role of oxygen in crosslinking of proteins by glucose (1992) (0)
In vivo sites of uptake of short- and long-lived circulating proteins: clearance of protein in peripheral tissue. (1980) (0)
Diabetic Retinal Microvascular Pathology is Prevented by Sulindac, a Non-steroidal Anti-inflammatory Drug, without Inhibition of Advanced Glycation, Polyol Pathway Activity or Oxidative Stress (2003) (0)
Methods for inhibiting oxidative modification of proteins (1999) (0)
Characterization of Glycated Proteins by 13 C NMR Spectroscopy (2019) (0)
Skeletal Muscle Oxidative Capacity in Cachectic Mice (2010) (0)
(2-succinyl)-cysteine (2SC): a Biomarker of Mitochondrial Stress in Type 2 Diabetes (2011) (0)
Site specifcity of fructoselysine (FL) and Ne-Carboxymethyl)lysine (CML) formation in ribonuclease-glucose model systems (2003) (0)
Inflammatory Cytokine IL‐6 and Cachectic Muscle Oxidative Capacity (2009) (0)
General Subjects Cumulative Contents (2006) (0)
Temporal Changes in Cardio‐Renal impairment in Type II Diabetic Rats. (2009) (0)
A rapid micro-modification of the quantitative immunoprecipitation assay. (1983) (0)
The Effect of Pyridoxamine Administration on Cachexia in ApcMin/+ Mice: 1958 (2008) (0)
Effect of Glucose and Glycation on Protein Oxidation (2005) (0)
Noninvasive Measurement of Advanced Glycation Endproducts Accumulation (2002) (0)
Evidence for Variations in Deglycating Activity among Tissues in the Diabetic Rat (2005) (0)
Treadmill Exercise And IL-6-induced Cachexia In The ApcMin/+ Mouse: 1710 (2010) (0)
IL‐6‐induced Cachexia and Muscle IGF‐1 Signaling (2010) (0)
Preface (2005) (0)
The Regulation of Skeletal Muscle Protein Turnover During the Progression of Cancer Cachexia in the ApcMin/+ Mouse (2020) (0)
Role of gut barrier dysfunction and endotoxemia in development of colon cancer cachexia (2010) (0)
Role of advanced glycation end products in non-diabetic proteinuria-induced renal damage in rat. (2003) (0)
The effect of oxidative capacity on mouse muscle protein synthesis during cachexia (2011) (0)
Carbohydrates and Lipids (2009) (0)
Synthesis and evaluation of radioactive and fluorescent residualizing labels for identifying sites of plasma protein catabolism (1986) (0)
"Atherosclerosis, diabetes and neurodegenerative diseases are more commonly associated with accumulation of iron in tissues, including both vascular and neurodegenerative plaque." (2013) (0)
Editors' Introduction: Welcome to the Special Issue on Diabetes Mellitus (2003) (0)
Detection of Age-Lipids in Vivo: Carboxymethylation of Aminophospholipids in LDL and Red Cell Membranes (2005) (0)
Characterization of an Imidazolium Compound Formed by Reaction of Methylglyoxal and Nα-Hippuryllysine. (1996) (0)
Medical biochemistry / John W. Baynes, Marek H. Dominiczak. (2019) (0)
Forum: Role of Oxidation in Atherosclerosis GLYCOXIDATION AND LIPOXIDATION IN ATHEROGENESIS (2000) (0)
In Vitro Quantitation of Advanced Glycation Endproducts in Porcine Dermis using Raman Spectroscopy (2004) (0)
Oxidation and glycoxidation of protein in diabetes and aging (1993) (0)
Increased glycated hemoglobin in non-diabetic patients : What does it mean ? (2006) (0)
Simultaneous Determination of Ascorbic and Dehydroascorbic Acids using Newly Developed HILIC Stationary Phases and Tandem Mass Spectrometry (2007) (0)
Enzymatic transfer of mannose from gdp-mannose to an endogenous lipid in mouse myeloma tumor (mopc-46). Abstr. (1972) (0)
Role of oxygen radical reactions in the browning and cross-linking of lysozyme by glucose (1986) (0)
Skeletal Muscle Protein Synthesis and IL-6 induced Cancer Cachexia. (2010) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With John W. Auteur Dominiczak Marek H. Auteur Baynes?

John W. Auteur Dominiczak Marek H. Auteur Baynes is affiliated with the following schools:

John W. Auteur Dominiczak Marek H. Auteur Baynes

John W. Auteur Dominiczak Marek H. Auteur Baynes's Academic­Influence.com Rankings

Why Is John W. Auteur Dominiczak Marek H. Auteur Baynes Influential?

John W. Auteur Dominiczak Marek H. Auteur Baynes's Published Works

Published Works

What Schools Are Affiliated With John W. Auteur Dominiczak Marek H. Auteur Baynes?

John W. Auteur Dominiczak Marek H. Auteur Baynes's AcademicInfluence.com Rankings